Citation Impact
Citing Papers
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
2007
Rab27a Supports Exosome-Dependent and -Independent Mechanisms That Modify the Tumor Microenvironment and Can Promote Tumor Progression
2012
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Tumor Vesicle—Associated CD147 Modulates the Angiogenic Capability of Endothelial Cells
2007
Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins
1999
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
2001
Chemokine Networks and Breast Cancer Metastasis
2007
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Inflammation and cancer
2002 StandoutNature
Endogenous inhibitors of angiogenesis
2009
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Chemokines and leukocyte traffic
1998 StandoutNature
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Tumor Self-Seeding by Circulating Cancer Cells
2009
Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe
2005
Clinical translation of angiogenesis inhibitors
2002 Standout
How Tumors Become Angiogenic
1996
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
1999 StandoutNature
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
2016
Exosomes
2013
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
2009
The antisense homology box: A new motif within proteins that encodes biologically active peptides
1995 StandoutNobel
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Tumor angiogenesis: past, present and the near future
2000
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis
1998
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
1997
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
2008 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Tumor targeting with a selective gelatinase inhibitor
1999
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Thrombospondins: from structure to therapeutics
2008
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
2003
Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth
2002
Role of endothelial cell survival and death signals in angiogenesis
1999
Angiogenesis in life, disease and medicine
2005 StandoutNature
Neuroligin 1: A splice site-specific ligand for β-neurexins
1995 StandoutNobel
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Regulation of LNS Domain Function by Alternative Splicing: The Structure of the Ligand-Binding Domain of Neurexin Iβ
1999 StandoutNobel
Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing
2008
Chemokines and their role in tumor growth and metastasis
1998
Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis
1999
Nicotine and pathological angiogenesis
2012
Molecular Mechanisms of Axon Growth and Guidance
1991
Cancer immunotherapy comes of age
2011 StandoutNature
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins
1997
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Chemokine Receptors CXCR-1/2 Activate Mitogen-activated Protein Kinase via the Epidermal Growth Factor Receptor in Ovarian Cancer Cells
2000
The Hallmarks of Aging
2013 Standout
The origin and function of tumor-associated macrophages
1992
The endothelin axis: emerging role in cancer
2003
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers
2012
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
2000
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
2007
Cancer-related inflammation
2008 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly
2003
Kaposi's Sarcoma
2000 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Studies in catalytic C–H amination involving nitrene C–H insertion
2010
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Changing views of the role of matrix metalloproteinases in metastasis
1997
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Thrombospondins and tumor angiogenesis
2001
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4
2004
Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.
1997
Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer
2016
A systems approach to cancer therapy
1996
TAXUS I
2003
The alphaviruses: gene expression, replication, and evolution
1994 Standout
Angiogenesis Research: Guidelines for Translation to Clinical Application
2001
Lymphatic vascular morphogenesis in development, physiology, and disease
2011
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
2001
Microvesicles: mediators of extracellular communication during cancer progression
2010
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
1997
Redefining the Target: Chemotherapeutics as Antiangiogenics
2001
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Making the cut: Protease-mediated regulation of angiogenesis
2006
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001
Functional mapping of disease susceptibility loci using cell biology
2006 StandoutNobel
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.
2002
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
2000
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Enantioselective Imidation of Sulfides via Enzyme-Catalyzed Intermolecular Nitrogen-Atom Transfer
2014 StandoutNobel
CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors
2018
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Biology and biogenesis of shed microvesicles
2016
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
Chemokines and tissue injury.
1995
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
2003
The Molecular Biology of Axon Guidance
1996 StandoutScience
Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.
2002
Angiogenesis in Endocrine Tumors
2003
Thrombospondin stimulates motility of human neutrophils.
1990 StandoutNobel
Taxane-Mediated Antiangiogenesis in Vitro
2004
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin
1992
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Giulia Taraboletti being referenced
Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte‐colony‐stimulating factor
1993
Thrombospondin modulates basic fibroblast growth factor activities on endothelial cells
1992
Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH
2006
Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
2000
Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells
2002
Cathepsin B Mediates the pH-Dependent Proinvasive Activity of Tumor-Shed Microvesicles
2008
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium
2004
Modulation of Laminin Receptor Expression by Estrogen and Progestins in Human Breast Cancer Cell Lines
1989
Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8
1990
Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases
1995
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
1998
Tumor‐derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues
1985
Functional domains of the 67-kDa laminin receptor precursor.
1991
Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
2002
The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells
2000
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
1999
Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endothelium.
1991
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration
1987 Nature
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.
1990
Ia antigen expression and IL-1 activity in murine tumour-associated macrophages.
1986
Role of laminin receptor in tumor cell migration.
1987
Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion
2008
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
1996
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent.
2003
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent
1987
The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
1997
Gorham-Stout Syndrome: A Monocyte-Mediated Cytokine Propelled Disease
2006
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
2003
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains.
1987
Sulfatide-binding domain of the laminin A chain.
1990